EXAS vs MBLY · rev $2.76B vs rev $1.89B
EXACT Sciences Corporation (EXAS) versus Mobileye Global Inc. Class A Common Stock (MBLY) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Mobileye Global Inc. Class A Common Stock (MBLY) is a auto parts company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported MBLY revenue for 2025-12-27 was $1.89B. Net income was -$392.0M. Revenue was up 14.5% from 2024-12-28 to 2025-12-27. MBLY currently screens at market cap $12.99B.
EXAS currently screens at market cap $20.03B. MBLY currently screens at market cap $12.99B.
Not investment advice. Open the EXAS and MBLY stock pages for the full models.
Not investment advice.